Maintenance Therapy With Anti-PD-1 Antibody for Patients With NK/T-cell Lymphoma
Clinical trial NCT04338282 · UNKNOWN
Trial details
- NCT number
- NCT04338282
- Sponsor
- Beijing Tongren Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-01
- Primary completion
- 2022-05-31
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.